跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Tranexaprime - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Tranexaprime
Approved
STANDARD
Tranexaprime
Gufic Biosciences Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
5948db475558f26c
Company
Gufic Biosciences Ltd.
Type
Standard
Approval Details
Approval Id
5948db475558f26c
Drug Approval Philippines Name
Tranexaprime
Product Name
Tranexaprime
Registration Number
DRP-5172-04
Brand Name
Tranexaprime
Generic Name
Tranexamic Acid
Dosage Form
Solution For Intravenous Injection
Dosage Strength
100 mg/mL (500 mg/5 mL)
Manufacturer
Gufic Biosciences Ltd.
Importer
Ambica International Corporation
Distributor
Primus Medicus Distributors Inc.
Company Detail Path
/organization/gufic-biosciences-ltd
Issuance Date
12 November 2023
Expiry Date
13 February 2029
Pharmacologic Category
Anti-Fibrinolytics
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
5948db475558f26c
Type
Standard
Back to Philippines FDA Approvals